How does a new Covid-19 variant respond to tests?
When a new variant of Covid-19 emerges, it alters the structure of the virus – but does that impact the results of tests?
Related Articles
Labcorp launches blood test for neurodegenerative diseases detection
Global life sciences company Labcorp has announced the first commercially available GFAP blood biomarker test in the US.
Telehealth clinical trial cuts hospital cardiac readmissions by 76%
The TELE-ACS designed to test SHL Telemedicine’s SmartHeart system was also able to significant drop emergency hospital visits by 41%.
Boston Scientific initiates study for PFA catheter system
The NAVIGATE-PF study will enrol 30 subjects across Europe with paroxysmal or persistent atrial fibrillation (AF).
Aventa Genomics introduces NGS test for solid tumours
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
CardioPrecision demonstrates new robotic cardiac surgery technique
The robotic surgery platform is aimed at speeding up aortic valve replacement surgeries whilst cutting down on staff.
Medtronic exits “unprofitable” ventilator market
Current North America and Europe market leader drops ventilator product lines, pivots to form Acute Care and Monitoring business.
Insulet touts results from Omnipod 5 trial in type 1 diabetes patients
The automated closed loop system delivered improved glycaemic and patient-reported outcomes versus traditional tech.
How 5G is changing the medical device landscape
Medical devices in Industry 4.0 are providing healthcare providers with greater amounts of data for more accurate diagnostics, but can fourth-generation connectivity keep up?
False empowerment: the misleading use of feminist narratives to market medical tests
New research has shown that some companies manipulate the narrative of women’s empowerment to sell AMH tests.
Europe’s proposed PFAS ban: The next big thing in medical device design and supply
The European Union could introduce a blanket ban on widely used PFAS chemicals as early as 2026. Here’s how it could impact medical devices.